Survey of current prenatal screening for Down syndrome in Australian hospitals providing maternity care

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 43, Issue 3, 2003, Pages 222-225

  Lawrence, Kathryn ^a   Crowther, Caroline A ^a  

^a Univ Dept of Obstetrics/Gynaecol   (United States)

Author keywords

Down syndrome; Maternal serum screening; Nuchal translucency screening; Screening tests

Indexed keywords

ARTICLE; AUSTRALIA; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GEOGRAPHY; HOSPITAL; HUMAN; MATERNAL CARE; MATERNAL SERUM; POSTAL MAIL; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

AUSTRALIA; DOWN SYNDROME; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HOSPITALS; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; QUESTIONNAIRES;

EID: 0037813059     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0004-8666.2003.00071.x     Document Type: Article

References (12)

1. Hurst T, Shafir E, Day P, Lancaster P. Congenital Malformations of Australia 1995-1996. Birth Defects Series 3. Sydney: Australian Institute of Health and Welfare, University of New South Wales, 1999.
2. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984; 148: 886-894.
3. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987; 7: 623-630.
4. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol. 1988; 95: 330-333.
5. Wald NJ, Cuckle HS, Densem JW et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ. 1988; 297: 883-887.
6. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn. 1996; 16: 143-153.
7. Wald NJ, Huttly WJ, Hennessy CF. Down's syndrome screening in the UK in 1998. Lancet. 1999; 354: 1264.
8. Macintosh M, Ellis A, Cuckle H, Seth J. Variation in biochemical screening for Down's syndrome in the United Kingdom. Br J Obstet Gynaecol. 1998; 105: 465-467.
9. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Statements 2001 Recommended 'Best Practice'. Guidelines on Antenatal Screening for Down Syndrome and Other Fetal Aneuploidy. Melbourne: Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2001.
10. Hyett J, Thilaganathan B. First trimester screening for fetal abnormalities. Curr Opin Obstet Gynecol. 1999; 11: 563-569.
11. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Med. Foundation First Trimester Screening Group. Lancet. 1998; 352: 343-346.
12. Kmietowicz Z. Warn the public of screening limitations, staff told. BMJ. 2000; 321: 914.